← Nazad


Allemani C



Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396-404]. Gynecol Oncol. 2017;147(3):725. [Šekerija M]

Autori: Matz M, Coleman MP, Carreira H, Salmeron D, Chirlaque MD, Allemani C, CONCORD Working Group
Godina: 2017

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2). Gynecol Oncol. 2017;144(2):396-404. [Šekerija M]

Autori: Matz M, Coleman MP, Carreira H, Salmeron D, Chirlaque MD, Allemani C, CONCORD Working Group
Godina: 2017

Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405-413]. Gynecol Oncol. 2017;147(3):726. [Šekerija M]

Autori: Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C, the CONCORD Working Group
Godina: 2017

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol. 2017;144(2):405-13. [Šekerija M]

Autori: Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C, the CONCORD Working Group
Godina: 2017

(Šekerija M) Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010.

Autori: Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS
Godina: 2015